BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1076 related articles for article (PubMed ID: 9543158)

  • 1. The follicle-stimulating hormone (FSH) threshold/window concept examined by different interventions with exogenous FSH during the follicular phase of the normal menstrual cycle: duration, rather than magnitude, of FSH increase affects follicle development.
    Schipper I; Hop WC; Fauser BC
    J Clin Endocrinol Metab; 1998 Apr; 83(4):1292-8. PubMed ID: 9543158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between inhibin A and B, estradiol and follicle growth dynamics during ovarian stimulation in normo-ovulatory women.
    Hohmann FP; Laven JS; de Jong FH; Fauser BC
    Eur J Endocrinol; 2005 Mar; 152(3):395-401. PubMed ID: 15757856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.
    Liu JH; Garzo G; Morris S; Stuenkel C; Ulmann A; Yen SS
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1135-40. PubMed ID: 2824550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
    Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
    J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of recombinant equine follicle stimulating hormone (reFSH) to promote follicular growth in mares using a follicular suppression model.
    Jennings MW; Boime I; Daphna-Iken D; Jablonka-Shariff A; Conley AJ; Colgin M; Bidstrup LA; Meyers-Brown GA; Famula TR; Roser JF
    Anim Reprod Sci; 2009 Dec; 116(3-4):291-307. PubMed ID: 19237253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human recombinant activin-A alters pituitary luteinizing hormone and follicle-stimulating hormone secretion, follicular development, and steroidogenesis, during the menstrual cycle in rhesus monkeys.
    Stouffer RL; Woodruff TK; Dahl KD; Hess DL; Mather JP; Molskness TA
    J Clin Endocrinol Metab; 1993 Jul; 77(1):241-8. PubMed ID: 8325947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease.
    Christman GM; Randolph JF; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1278-85. PubMed ID: 1902845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome.
    Filicori M; Cognigni GE; Taraborrelli S; Spettoli D; Ciampaglia W; de Fatis CT; Pocognoli P
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2659-63. PubMed ID: 10443656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of multiple follicular development by a single dose of long-acting recombinant follicle-Stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization.
    Devroey P; Fauser BC; Platteau P; Beckers NG; Dhont M; Mannaerts BM
    J Clin Endocrinol Metab; 2004 May; 89(5):2062-70. PubMed ID: 15126522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-dose exogenous FSH initiated during the early, mid or late follicular phase can induce multiple dominant follicle development.
    Hohmann FP; Laven JS; de Jong FH; Eijkemans MJ; Fauser BC
    Hum Reprod; 2001 May; 16(5):846-54. PubMed ID: 11331627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired folliculogenesis and ovulation in older reproductive aged women.
    Santoro N; Isaac B; Neal-Perry G; Adel T; Weingart L; Nussbaum A; Thakur S; Jinnai H; Khosla N; Barad D
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5502-9. PubMed ID: 14602797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing of FSH administration for ovarian stimulation in normo-ovulatory women: comparison of an early or a mid follicular phase initiation of a short-term treatment.
    Cedrin-Durnerin I; Massin N; Galey-Fontaine J; Bry-Gauillard H; Roger M; Lahlou N; Hugues JN
    Hum Reprod; 2006 Nov; 21(11):2941-7. PubMed ID: 16877377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of inhibin A and inhibin B by luteinizing hormone, follicle-stimulating hormone, and stage of follicle development.
    Welt CK; Smith ZA; Pauler DK; Hall JE
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2531-7. PubMed ID: 11397851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follicular arrest during the midfollicular phase of the menstrual cycle: a gonadotropin-releasing hormone antagonist imposed follicular-follicular transition.
    Kettel LM; Roseff SJ; Chiu TC; Bangah ML; Vale W; Rivier J; Burger HG; Yen SS
    J Clin Endocrinol Metab; 1991 Sep; 73(3):644-9. PubMed ID: 1908486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in thecal and granulosa cell LH and FSH receptor content associated with follicular fluid and peripheral plasma gonadotrophin and steroid hormone concentrations in preovulatory follicles of mares.
    Fay JE; Douglas RH
    J Reprod Fertil Suppl; 1987; 35():169-81. PubMed ID: 3119827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression in the secretion of follicle-stimulating hormone and luteinizing hormone, and ovarian follicle development in heifers continuously infused with a gonadotropin-releasing hormone agonist.
    Gong JG; Campbell BK; Bramley TA; Gutierrez CG; Peters AR; Webb R
    Biol Reprod; 1996 Jul; 55(1):68-74. PubMed ID: 8793060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian responses in women to recombinant follicle-stimulating hormone and luteinizing hormone (LH): a role for LH in the final stages of follicular maturation.
    Sullivan MW; Stewart-Akers A; Krasnow JS; Berga SL; Zeleznik AJ
    J Clin Endocrinol Metab; 1999 Jan; 84(1):228-32. PubMed ID: 9920089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of daily low dose mifepristone on the ovarian cycle and on dynamics of follicle growth.
    Cameron ST; Thong KJ; Baird DT
    Clin Endocrinol (Oxf); 1995 Oct; 43(4):407-14. PubMed ID: 7586613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadotropin-releasing hormone, estradiol, and inhibin regulation of follicle-stimulating hormone and luteinizing hormone surges: implications for follicle emergence and selection in heifers.
    Haughian JM; Ginther OJ; Diaz FJ; Wiltbank MC
    Biol Reprod; 2013 Jun; 88(6):165. PubMed ID: 23658431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FSH and ovarian response: spontaneous recovery of pituitary-ovarian activity during the pill-free period vs. exogenous recombinant FSH during high-dose combined oral contraceptives.
    van Heusden AM; Coelingh Bennink HJ; Fauser BC
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):509-17. PubMed ID: 11966744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 54.